DENTSPLY SIRONA Inc.

For the period ended Sep 30, 2025. Filed Nov 6, 2025.

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 6, 2025

XRAY$9.54+0.8%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

Consolidated Statements of Operations

(in millions, except per share amounts)

	Three Months Ended September 30,		Nine Months Ended September 30,
	2025	2024	2025	2024
Net sales	$904	$951	$2,719	$2,888
Cost of products sold	463	456	1,322	1,376
Gross profit	441	495	1,397	1,512
Selling, general, and administrative expenses	355	390	1,055	1,204
Research and development expenses	37	40	110	123
Goodwill and intangible asset impairments	262	504	497	510
Restructuring and other costs	5	23	18	45
Operating loss	(218)	(462)	(283)	(370)
Other income and expenses:
Interest expense, net	23	18	66	53
Other income	(11)	(2)	(10)	(10)
Loss before income taxes	(230)	(478)	(339)	(413)
Provision for income taxes	198	17	114	69
Net loss	(428)	(495)	(453)	(482)
Less: Net loss attributable to noncontrolling interest	(1)	(1)	(1)	(2)
Net loss attributable to Dentsply Sirona	$(427)	$(494)	$(452)	$(480)
Loss per common share attributable to Dentsply Sirona:
Basic	$(2.14)	$(2.46)	$(2.27)	$(2.35)
Diluted	$(2.14)	$(2.46)	$(2.27)	$(2.35)
Weighted average common shares outstanding:
Basic	199.5	201.0	199.3	204.7
Diluted	199.5	201.0	199.3	204.7

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.